We are live on ! Find out more
CRDL

Cardiol Therapeutics
CRDL

38 hedge funds and large institutions have $8.8M invested in Cardiol Therapeutics in 2025 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more capital invested

Capital invested by funds: $7.44M → $8.8M (+$1.36M)

0% more funds holding

Funds holding: 38 → 38 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

1.64% less ownership

Funds ownership: 9.46% → 7.82% (-1.6%)

18% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 11

Holders
38
Holders Change
–
Holders Change %
0%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
9
Reduced
11
Closed
7
Calls
$177K
Puts
–
Net Calls
+$177K
Net Calls Change
+$24K

Top Buyers

Rank Fund Capital Flow
1
TC
Tejara Capital
United Kingdom
+$82.5K
2
Morgan Stanley
Morgan Stanley
New York
+$46.9K
3
Mercer Global Advisors
Mercer Global Advisors
Colorado
+$26.3K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$23.3K
5
Goldman Sachs
Goldman Sachs
New York
+$21.3K

Top Sellers

Rank Fund Capital Flow
1
MI
MMCAP International
Cayman Islands
-$570K
2
UBS Group
UBS Group
Switzerland
-$417K
3
PAM
PVG Asset Management
Colorado
-$179K
4
Envestnet Asset Management
Envestnet Asset Management
Illinois
-$172K
5
AI
AdvisorShares Investments
Maryland
-$146K
Name Holding Trade Value Shares
Change 		Change in
Stake
MA
26
MONECO Advisors
Connecticut
$20.4K +$17.5K +15,000 New
Janney Montgomery Scott
27
Janney Montgomery Scott
Pennsylvania
$19K +$16.5K +14,200 New
IAA
28
Independent Advisor Alliance
North Carolina
$13.6K – – –
National Bank of Canada
29
National Bank of Canada
Quebec, Canada
$12.5K +$757 +650 +8%
Group One Trading
30
Group One Trading
Illinois
$10.5K -$853 -733 -9%
PSB
31
Piscataqua Savings Bank
New Hampshire
$10.3K – – –
TWC
32
TD Waterhouse Canada
Ontario, Canada
$8.96K – – –
Raymond James Financial
33
Raymond James Financial
Florida
$8.37K +$7.16K +6,154 New
VNA
34
Valley National Advisers
Pennsylvania
$6K – – –
Osaic Holdings
35
Osaic Holdings
Arizona
$5.45K -$320 -275 -6%
SC
36
SouthState Corp
Florida
$1.36K – – –
SS
37
SBI Securities
Japan
$649 +$2 +2 +0.4%
PPA
38
Painted Porch Advisors
California
$200 – – –
UBS AM
39
UBS AM
Illinois
– -$53.4K -55,000 Closed
VF
40
Virtu Financial
New York
– -$16K -16,038 Closed
EPIM
41
Evelyn Partners Investment Management
– -$9.52K -10,000 Closed
HFM
42
Hartford Financial Management
Connecticut
– -$3.88K -4,000 Closed
TRCT
43
Tower Research Capital (TRC)
New York
– -$114 -118 Closed
SHIM
44
Stone House Investment Management
Pennsylvania
– -$48 -50 Closed
Wells Fargo
45
Wells Fargo
California
– -$24 -25 Closed
1
2

CRDL Hedge Fund Activity: Q2 2025 in Review

38 of the 7,598 institutional investors tracked by Wall St. Rank reported a position in Cardiol Therapeutics (CRDL) for Q2 2025, worth a combined $8.8M — up 18% from $7.44M a quarter earlier.

Fund positioning in CRDL was balanced in Q2 2025: 7 funds opened new positions, 7 closed out, 9 added to existing stakes and 11 trimmed.

The largest buyer was Tejara Capital, adding an estimated $82.5K. The largest seller was MMCAP International, cutting an estimated $570K.

  • 38 institutional investors held Cardiol Therapeutics (CRDL) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $8.8M of Cardiol Therapeutics stock for Q2 2025, up 18% quarter-over-quarter.
  • 7 funds opened new Cardiol Therapeutics positions in Q2 2025 and 7 closed out, a net change of 0 holders.
  • The largest Cardiol Therapeutics buyer in Q2 2025 was Tejara Capital, an estimated $82.5K added.
  • The largest Cardiol Therapeutics seller in Q2 2025 was MMCAP International, an estimated $570K sold.

Based on aggregated 13F filings for Q2 2025.